PL1708711T3 - Kompozycje użyteczne zwłaszcza w leczeniu lub zapobieganiu zespołowi metabolicznemu - Google Patents

Kompozycje użyteczne zwłaszcza w leczeniu lub zapobieganiu zespołowi metabolicznemu

Info

Publication number: PL1708711T3
Authority: PL; Poland
Prior art keywords: prevention; treatment; metabolic syndrome; enzyme inhibitor; oxidase enzyme
Prior art date: 2004-01-30

Application number

PL05708123T

Other languages

English (en)

Inventor

Sirpa Jalkanen

Marko Salmi

Markku Jalkanen

Original Assignee

Biotie Therapies Oyj

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-30

Filing date

2005-01-19

Publication date

2010-10-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34828616&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1708711(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-01-30 Priority claimed from FI20040136A external-priority patent/FI20040136A0/fi

2005-01-19 Application filed by Biotie Therapies Oyj filed Critical Biotie Therapies Oyj

2010-10-29 Publication of PL1708711T3 publication Critical patent/PL1708711T3/pl

Links

208000001145 Metabolic Syndrome Diseases 0.000 title abstract 2
201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title abstract 2
230000002265 prevention Effects 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
102000004316 Oxidoreductases Human genes 0.000 abstract 4
108090000854 Oxidoreductases Proteins 0.000 abstract 4
229940125532 enzyme inhibitor Drugs 0.000 abstract 4
239000002532 enzyme inhibitor Substances 0.000 abstract 4
238000004519 manufacturing process Methods 0.000 abstract 2
239000000825 pharmaceutical preparation Substances 0.000 abstract 2
229930003451 Vitamin B1 Natural products 0.000 abstract 1
235000013305 food Nutrition 0.000 abstract 1
235000013373 food additive Nutrition 0.000 abstract 1
239000002778 food additive Substances 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
208000030159 metabolic disease Diseases 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 abstract 1
229960003495 thiamine Drugs 0.000 abstract 1
239000011691 vitamin B1 Substances 0.000 abstract 1
235000010374 vitamin B1 Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Immunology (AREA)
Child & Adolescent Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Reproductive Health (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Vascular Medicine (AREA)

PL05708123T 2004-01-30 2005-01-19 Kompozycje użyteczne zwłaszcza w leczeniu lub zapobieganiu zespołowi metabolicznemu PL1708711T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FI20040136A FI20040136A0 (fi)	2004-01-30	2004-01-30	Erityisesti diabeetikoille soveltuvia koostumuksia
US57889604P	2004-06-14	2004-06-14
EP05708123A EP1708711B1 (en)	2004-01-30	2005-01-19	Compositions useful especially for treatment or prevention of metabolic syndrome
PCT/FI2005/000035 WO2005072738A1 (en)	2004-01-30	2005-01-19	Compositions useful especially for treatment or prevention of metabolic syndrome

Publications (1)

Publication Number	Publication Date
PL1708711T3 true PL1708711T3 (pl)	2010-10-29

Family

ID=34828616

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05708123T PL1708711T3 (pl)	2004-01-30	2005-01-19	Kompozycje użyteczne zwłaszcza w leczeniu lub zapobieganiu zespołowi metabolicznemu

Country Status (12)

Country	Link
EP (1)	EP1708711B1 (pl)
JP (1)	JP2007519688A (pl)
AT (1)	ATE460935T1 (pl)
CA (1)	CA2549029A1 (pl)
CY (1)	CY1110194T1 (pl)
DE (1)	DE602005019974D1 (pl)
DK (1)	DK1708711T3 (pl)
ES (1)	ES2342409T3 (pl)
PL (1)	PL1708711T3 (pl)
PT (1)	PT1708711E (pl)
SI (1)	SI1708711T1 (pl)
WO (1)	WO2005072738A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI20060768A0 (fi) *	2006-08-28	2006-08-28	Faron Pharmaceuticals Oy	Erityisesti metabolia-oireyhtymän hoitoon tai ehkäisyyn soveltuvia koostumuksia
US8119651B2 (en)	2004-01-30	2012-02-21	Biotie Therapies Corp.	Compositions useful especially for treatment or prevention of metabolic syndrome
ITMI20050891A1 (it) *	2005-05-17	2006-11-18	Greenleaf S R L	Formulazioni per il trattamento di psoriasi
KR20100096094A (ko) *	2007-10-19	2010-09-01	가부시키가이샤 아루떼꾸 우에노	백내장 처치를 위한 의약 조성물
UA112154C2 (uk)	2009-09-08	2016-08-10	Біоті Терапіс Корп.	Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів
CN102498091B (zh)	2009-09-16	2014-03-05	安斯泰来制药株式会社	甘氨酸化合物
AU2015299739B2 (en) *	2014-08-04	2020-05-14	Commonwealth Scientific And Industrial Research Organisation	Methods for formulating dietary foodstuffs
CN108299485B (zh) *	2018-02-09	2020-05-12	湖北大学	一种用于检测活细胞内过氧化氢的荧光探针及其制备方法和应用
WO2021059275A1 (en) *	2019-09-26	2021-04-01	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center)	Thiamine therapy for fatty liver associated diseases
CN110713986B (zh) *	2019-11-12	2023-05-12	江南大学	一株维生素b1单克隆抗体杂交瘤细胞株cbdd及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5441883A (en) *	1977-09-05	1979-04-03	Takeda Chem Ind Ltd	Thiamine derivative and its preparation
US4558050A (en) *	1984-03-01	1985-12-10	University Of Florida	Treatment of metabolic disorders with dichloroacetate-thiamine preparations
JPH01104142A (ja) *	1987-10-19	1989-04-21	Seibutsu Shigen Kenkyusho:Kk	消臭機能性食品及びその製造法
JP3942257B2 (ja) *	1998-01-06	2007-07-11	希能澤口	機能性食品
IL153767A0 (en) *	2000-07-05	2003-07-06	Biotie Therapies Corp	Inhibitors of copper-containing amine oxidases
DE10043802A1 (de)	2000-09-06	2002-03-14	Daimler Chrysler Ag	Achse für Fahrzeuge, insbesondere Nutzfahrzeuge
AU2002214505A1 (en) *	2000-11-09	2002-05-21	Biovitrum Ab	New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives
JP2002193826A (ja) *	2000-12-26	2002-07-10	Fancl Corp	強壮・強精組成物
US6982286B2 (en)	2001-07-12	2006-01-03	Biotie Therapies Corp.	Carbocyclic hydrazino inhibitors of copper-containing amine oxidases

2005
- 2005-01-19 DK DK05708123.4T patent/DK1708711T3/da active
- 2005-01-19 JP JP2006550207A patent/JP2007519688A/ja active Pending
- 2005-01-19 ES ES05708123T patent/ES2342409T3/es not_active Expired - Lifetime
- 2005-01-19 SI SI200531026T patent/SI1708711T1/sl unknown
- 2005-01-19 EP EP05708123A patent/EP1708711B1/en not_active Revoked
- 2005-01-19 PL PL05708123T patent/PL1708711T3/pl unknown
- 2005-01-19 AT AT05708123T patent/ATE460935T1/de active
- 2005-01-19 PT PT05708123T patent/PT1708711E/pt unknown
- 2005-01-19 CA CA002549029A patent/CA2549029A1/en not_active Abandoned
- 2005-01-19 WO PCT/FI2005/000035 patent/WO2005072738A1/en not_active Ceased
- 2005-01-19 DE DE602005019974T patent/DE602005019974D1/de not_active Expired - Lifetime
2010
- 2010-06-11 CY CY20101100523T patent/CY1110194T1/el unknown

Also Published As

Publication number	Publication date
SI1708711T1 (sl)	2010-07-30
JP2007519688A (ja)	2007-07-19
ES2342409T3 (es)	2010-07-06
DE602005019974D1 (de)	2010-04-29
DK1708711T3 (da)	2010-06-14
ATE460935T1 (de)	2010-04-15
CA2549029A1 (en)	2005-08-11
CY1110194T1 (el)	2015-01-14
WO2005072738A1 (en)	2005-08-11
PT1708711E (pt)	2010-06-01
EP1708711A1 (en)	2006-10-11
EP1708711B1 (en)	2010-03-17

Publication	Publication Date	Title
CY1110194T1 (el)	2015-01-14	Ενωσεις ιδιαιτερα χρησιμες για την αγωγη ή προληψη του μεταβολικου συνδρομου
TW200744639A (en)	2007-12-16	Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
IL186788A0 (en)	2008-02-09	Nutritional supplement for hiv patients
WO2007061661A3 (en)	2008-12-11	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2007093450A3 (en)	2007-09-27	Deuterated catecholamine derivatives and medicaments comprising said compounds
MY147503A (en)	2012-12-14	Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person
WO2007088062A3 (en)	2008-09-12	Food product comprising a proline specific protease
GEP20094666B (en)	2009-04-10	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MX2007008021A (es)	2008-04-11	Composiciones que incluyen hierro.
WO2008021531A3 (en)	2008-05-08	Stabilized emulsions, methods of preparation, and related reduced fat foods
IL154318A0 (en)	2003-09-17	Pharmaceutical compositions for the treatment of movement disorders
TW200507767A (en)	2005-03-01	Compositions containing coenzyme Q10
WO2008079610A3 (en)	2008-08-14	Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
WO2008046865A3 (en)	2008-12-11	Long-term feed - elderly
WO2008057300A3 (en)	2008-06-12	Trpvi antagonists and uses thereof
WO2009038095A1 (ja)	2009-03-26	セサミン類とビタミンｂ１類とを配合した組成物
WO2007137297A3 (en)	2009-09-11	Foods and beverages with additives
MX2007003196A (es)	2007-05-16	Agente y alimento para evitar/mejorar el trastorno digestivo funcional.
WO2007070562A3 (en)	2008-11-27	Non-hygroscopic compositions of enterostatin
WO2006128048A3 (en)	2009-04-23	Methods and compositions for reducing blood homocysteine levels
MX2007009410A (es)	2008-04-29	Aditivo alimenticio para rumiantes a base de eugenol y de cinamaldehido.
WO2007035933A3 (en)	2007-05-18	Composition for reducing fat megration in food products
MX2007015542A (es)	2008-04-17	Composiciones y productos alimenticios espesados con acido.
WO2006109194A3 (en)	2006-12-07	Chromium-fatty acid compounds and methods of making and using thereof
MX2007004881A (es)	2007-07-04	Ingredientes alimenticios bioactivos protectores utilizando microorganismos que tienen capacidad metabolizante reducida.